Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 53 pages
Exam (elaborations)

N212 Pathophysiology 2026 Actual Test Bank | Eastwick College | 200+ Questions with Correct Answers & Detailed Rationales | Latest Update

Document preview thumbnail
Preview 4 out of 53 pages

Pass your N212 Pathophysiology Exam 2 at Eastwick College on the first attempt. This comprehensive practice test bank contains 200+ original, high-yield questions covering all N212 Exam 2 domains, including cellular adaptation and injury, inflammation and healing, fluid and electrolyte balance, acid-base disorders, immune system disorders, neoplasia and cancer biology, genetic and developmental disorders, cardiovascular system disorders, respiratory system disorders, renal and urinary system disorders, and endocrine system disorders. Complete with detailed rationales explaining correct answers and why distractors are wrong. Updated for the 2026 testing cycle. What's included in this exam bank: Section 1: Cellular Adaptation and Injury (Questions 1-20) Barrett esophagus – metaplasia (reversible change due to chronic irritation) Mitochondrial toxin (complex I inhibition) – ATP depletion and Na+/K+ ATPase failure (first consequence) Cardiac myocytes hypertrophy (not hyperplasia) – terminally differentiated, exited cell cycle Renal artery stenosis atrophy – reduced blood flow and decreased workload Hydrogen peroxide reversible injury – mitochondrial swelling and membrane blebbing (reversible) Viral hepatitis hepatocyte apoptosis – cell shrinkage, eosinophilic cytoplasm, pyknosis (Councilman bodies) Transition from reversible to irreversible ischemia – massive calcium influx (activates phospholipases/proteases) Superoxide dismutase (SOD) deficiency – increased susceptibility to reperfusion injury Hemochromatosis hemosiderin – intracellular accumulation of endogenous pigment (excess substrate) UPR inhibitor under ER stress – failure to reduce misfolded proteins → increased apoptosis Chronic hypoxia adaptation – upregulation of HIF-1α (glycolysis, angiogenesis) Proteasome inhibitor impaired – autophagy of damaged organelles Earliest reversible cell injury – swelling of mitochondria and endoplasmic reticulum Iron overload injury – chemical injury via free radical generation (Fenton reaction) Hyperplasia – increase in cell number Defective autophagy – accumulation of lipofuscin granules Barrett esophagus – metaplasia Cytochrome c in apoptosis – activates caspases after release from mitochondria ATP synthase inhibition – increased glycolysis and lactic acidosis Irreversible cell injury – flocculent densities in mitochondria Section 2: Inflammation and Healing (Questions 21-40) Immediate vasodilation and increased permeability – histamine Chronic non-healing wound poor epithelialization – EGF deficiency M2 macrophage phenotype (tissue repair, fibrosis) – IL-4 Firm adhesion and transmigration of neutrophils – integrins and immunoglobulin superfamily (ICAM-1) Granuloma with central necrosis – tuberculosis Collagen synthesis in wound healing – fibroblasts DIC coagulation activation – tissue factor Resolution of inflammation (clearance of apoptotic neutrophils) – Resolvin E1 NSAID mechanism – inhibition of COX-2 (decreased prostaglandin synthesis) Chronic venous stasis ulcer impaired healing – persistent hypoxia due to venous hypertension NSAIDs vs. corticosteroids – NSAIDs block COX; corticosteroids inhibit phospholipase A2 (all eicosanoids + cytokines) Chronic inflammation critical switch – shift from neutrophil to macrophage predominance with persistent activation Venous stasis ulcer mechanism – ischemia-reperfusion injury and iron-catalyzed free radicals Proliferative phase provisional matrix synthesis – myofibroblasts Keloid histology – abundant myofibroblasts and disorganized collagen type III NLRP3 inflammasome inhibitor – IL-1β directly affected Lipoxins in resolution – stimulate macrophage phagocytosis of apoptotic neutrophils (efferocytosis) Biofilm impairment – persistent neutrophil-dominated inflammation (degrades growth factors and ECM) Fetal wound healing scarless – reduced TGF-β and increased IL-10 iNOS deficiency slower healing – antimicrobial activity and stimulation of collagen synthesis Section 3: Fluid, Electrolyte, and Acid-Base Imbalances (Questions 41-60) SIADH hyponatremia – increased renal reabsorption of water dilutes sodium CKD hyperkalemia – impaired renal potassium secretion in distal tubule under aldosterone influence Severe vomiting ABG: pH 7.52, PaCO2 48, HCO3- 38 – metabolic alkalosis with inappropriate respiratory acidosis (PaCO2 lower than expected) Hypercalcemia polyuria/polydipsia – impairs aquaporin-2 insertion (nephrogenic diabetes insipidus) DKA pH 7.1, PaCO2 20, HCO3- 8 – appropriate compensation (Winter's formula: expected PaCO2 20) Hyperaldosteronism metabolic alkalosis – aldosterone increases H+ secretion in collecting duct Chronic respiratory acidosis with renal compensation – pH 7.36, PaCO2 50, HCO3- 28 Pancreatitis hypocalcemia – saponification of calcium with free fatty acids Loop diuretics metabolic alkalosis – increased sodium delivery to distal nephron enhances K+/H+ exchange COPD ABG: pH 7.33, PaCO2 65, HCO3- 34 – hypochloremia (Cl 88) CKD metabolic acidosis – impaired distal hydrogen ion secretion (decreased net acid excretion) SIADH Na 118, hypertonic saline overcorrection – central pontine myelinolysis Primary respiratory alkalosis 2 days – pH 7.52, PaCO2 25, HCO3- 20 Severe vomiting: Na 136, K 3.0, Cl 88, HCO3- 32, pH 7.50, PaCO2 48 – metabolic alkalosis with appropriate compensation Pancreatitis hypocalcemia (ionized Ca 0.8) – elevated PTH (compensatory) Hypernatremia from diabetes insipidus – 5% dextrose in water (D5W) provides free water Cirrhosis hyponatremia – impaired renal water excretion due to nonosmotic ADH release COPD chronic respiratory acidosis – pH 7.33, PaCO2 65, HCO3- 34 (chronic with appropriate compensation) Massive transfusion hyperkalemia – stored blood releases potassium DKA K+ 3.0 – acidosis-induced shift of potassium extracellularly (masks total body depletion) Section 4: Immune System Disorders (Questions 61-80) Anti-IgE monoclonal antibody – prevents IgE from binding to FcεRI (inhibits mast cell degranulation) Goodpasture syndrome immunoglobulin subclass – IgG Terminal complement deficiency (C5-C9) – Neisseria meningitidis Rheumatoid arthritis ectopic lymphoid structures – follicular dendritic cells presenting antigen to B cells X-linked agammaglobulinemia BTK mutation – pro-B to pre-B cell transition arrest Central tolerance unique process – clonal deletion of developing thymocytes with high affinity for self-peptide-MHC Chronic GVHD – donor T cells attacking host tissues (skin, liver, GI) Recurrent infections, defective neutrophil chemotaxis – leukocyte adhesion deficiency type 1 (LAD-1) DRESS syndrome – type IV hypersensitivity (drug-specific T cell activation) SLE anti-dsDNA lupus nephritis – form immune complexes that deposit in glomeruli, activating complement Low IgG and IgA, normal IgM, autoimmune hemolytic anemia – common variable immunodeficiency (CVID) Anti-CD52 monoclonal antibody – complement-dependent cytotoxicity and ADCC depleting lymphocytes ADA SCID – deoxyadenosine triphosphate (dATP) accumulation (lymphotoxicity) Radiocontrast anaphylactoid reaction – direct complement activation (C3a, C5a) SLE renal injury – subendothelial deposits with granular immunofluorescence TNF-α inhibitor adverse effect – reactivation of latent tuberculosis EAE demyelination – CD4+ Th17 cells secreting IL-17 CGD liver abscess – Pseudomonas cepacia (catalase-positive) Selective IgA deficiency autoimmunity – impaired mucosal barrier → increased antigen absorption Hereditary angioedema – increased bradykinin production (uncontrolled contact system activation) Section 5: Neoplasia and Cancer Pathophysiology (Questions 81-100) HIF-1α stabilization – upregulation of VEGF, GLUT1, PDK1 (angiogenesis, metabolic reprogramming) MSI-high colorectal cancer favorable prognosis – high neoantigen load elicits robust anti-tumor immune response CTNNB1 mutation (β-catenin) – Wnt/β-catenin signaling activation BH3 mimetic (BCL-2 inhibitor) greatest efficacy – CLL with high BCL-2 expression HER2/neu breast cancer targeted therapy – tyrosine kinase inhibitor (lapatinib) binding ATP pocket Squamous metaplasia progression – metaplasia → dysplasia → carcinoma in situ → invasive carcinoma E-cadherin loss – epithelial-mesenchymal transition (EMT) enhanced Tumor suppressor in DNA damage response (p53 phosphorylation) – CHK2 Telomerase reactivation oncogenic risk – unlimited replicative potential (immortalization) BRCA1 HRR deficiency selective toxicity – PARP inhibitor (olaparib) synthetic lethality Constitutively active transcription factor oncogene – sustained activation of cell cycle progression genes BRCA1 mutation mechanism – defective homologous recombination repair (genomic instability) LOH in sporadic colon cancer – one allele deleted, remaining wild-type mutated/silenced PD-L1 immune evasion – engagement of PD-1 on CTLs (inhibits their activity) Malignant vs. benign histology – high mitotic rate with atypical mitotic figures Chemical carcinogen initiation – DNA adduct → error-prone repair → permanent mutation in critical gene Colorectal adenoma to carcinoma transition – TP53 mutation HCV hepatocellular carcinoma – chronic inflammation → oxidative stress → DNA damage Proteasome inhibitor anticancer activity – stabilization of IκB (inhibits NF-κB signaling) Telomerase in cancer cells – maintains telomere length (unlimited replicative potential) Section 6: Genetic and Developmental Disorders (Questions 101-120) H3K9me3 methyltransferase mutation – impaired heterochromatin formation (ectopic expression of silenced genes) X-linked recessive: carrier mother, unaffected father – 50% sons affected, 50% daughters carriers Fragile X anticipation – meiotic instability of CGG repeat (expansion during maternal meiosis) Turner syndrome (45,X) – nondisjunction in maternal meiosis I Disorder manifests only when inherited from mother – mutation in paternally expressed imprinted gene (maternal allele silenced) Holoprosencephaly SHH deletion – autosomal dominant with incomplete penetrance (haploinsufficiency) BRCA1 tumor suppressor – loss of heterozygosity leads to impaired DNA repair DiGeorge syndrome 22q11.2 deletion – neural crest cell migration into pharyngeal arches Trisomy 21 mechanism – nondisjunction in maternal meiosis I (most common) MTHFR SNP and neural tube defects – multifactorial inheritance with genetic susceptibility factor Chromatin remodeling mutation – transcriptional regulation via epigenetic modification ADPKD obligate carrier with no cysts (age 60) – incomplete penetrance Balanced translocation (2;5) with miscarriages – missegregation during meiosis leading to unbalanced gametes SCID with homozygous deletion of chromosome 22 gene – autosomal recessive Centrosome mutation – mitotic spindle formation disrupted Prader-Willi paternal deletion – Angelman syndrome (maternal deletion) RAD51C deletion – homologous recombination repair compromised Achondroplasia, average stature parents – de novo dominant mutation in FGFR3 CGG repeat expansion → promoter hypermethylation → silencing – Fragile X syndrome HFE C282Y homozygote, normal iron – incomplete penetrance Section 7: Cardiovascular System Disorders (Questions 121-140) Aortic stenosis chronic pressure overload – concentric hypertrophy (decreased ventricular compliance) Chronic mitral regurgitation pulmonary edema – increased left atrial pressure → pulmonary venous hypertension Atrial fibrillation thromboembolism – stasis of blood in left atrial appendage Anterior STEMI new holosystolic murmur at apex – papillary muscle rupture (acute mitral regurgitation) Hypertrophic cardiomyopathy dynamic LVOT obstruction – systolic anterior motion of mitral valve leaflet Chronic hypertension LV hypertrophy – decreased coronary perfusion pressure (elevated LVEDP) ASD Eisenmenger syndrome – chronic left-to-right shunt → pulmonary vascular remodeling → reversed shunt Dilated cardiomyopathy EF 25% – activation of RAAS (fibrosis and remodeling, disease progression) Diabetes orthostatic hypotension + resting tachycardia – autonomic neuropathy (impaired baroreflex, sympathetic denervation) Cardiac tamponade hemodynamic finding – equalization of diastolic pressures in all four chambers Decompensated heart failure – activation of RAAS (vasoconstriction and fluid retention) STEMI irreversible necrosis – prolonged severe ischemia 20-30 minutes (failure of anaerobic metabolism) Severe aortic stenosis with preserved LVEF – increased LVEDP, decreased stroke volume, decreased aortic pulse pressure Atrial fibrillation acute leg ischemia – embolization of thrombus from left atrial appendage Endothelial dysfunction in atherosclerosis – increased expression of VCAM-1 (loss of NO bioavailability) Hypertensive emergency retinal findings – fibrinoid necrosis of retinal arterioles Chronic heart failure elevated BNP – ventricular myocytes secrete BNP in response to increased wall tension Infective endocarditis acute heart failure – acute aortic regurgitation (leaflet perforation) Dilated cardiomyopathy maladaptive compensation – increased sympathetic nervous system activity VSD pulmonary hypertension mechanism – increased pulmonary blood flow → shear stress → vascular remodeling Section 8: Respiratory System Disorders (Questions 141-160) COPD exacerbation: pH 7.28, PaCO2 65, HCO3- 26 – acute respiratory acidosis without renal compensation COPD polycythemia – enhanced renal production of erythropoietin (chronic hypoxemia) Acute asthma exacerbation bronchoconstriction – mast cell degranulation → histamine → H1 receptor activation → calcium influx → contraction Pulmonary fibrosis low DLCO – thickening of alveolar-capillary membrane (collagen deposition) ARDS PaO2/FiO2 150 hypoxemia – intrapulmonary shunting (alveolar flooding and collapse) Pulmonary embolism large clot – increased alveolar dead space and widened A-a gradient Cystic fibrosis progressive FEV1/FVC decline – airway obstruction (thick mucus, chronic inflammation, air trapping) Severe kyphoscoliosis PFT pattern – reduced TLC and RV, preserved FEV1/FVC (restrictive) COPD cor pulmonale – pulmonary vasoconstriction from chronic alveolar hypoxia (right ventricular hypertrophy) 40 pack-year, FEV1/FVC 0.55, DLCO 40% – emphysema COPD acute hypercapnia (PaCO2 65, baseline 50) – rightward shift (increased CO2, decreased pH → oxygen unloading) ARDS refractory hypoxemia – V/Q mismatch with intrapulmonary shunting Alpha-1 antitrypsin deficiency panacinar emphysema – unopposed elastase activity throughout acinus Cold air asthma bronchoconstriction – direct stimulation of vagal afferents (reflex cholinergic-mediated constriction) Pulmonary embolism hypoxemia – right-to-left shunting through patent foramen ovale PAH vs. pulmonary venous hypertension – increased PVR with normal PCWP Cystic fibrosis early pathogenesis – impaired mucociliary clearance (defective CFTR → thick mucus) IPF hypoxemia mechanism – diffusion limitation across thickened alveolar-capillary membrane Large pleural effusion hypoxemia – compression atelectasis → intrapulmonary shunt OSA pulmonary hypertension – hypoxic pulmonary vasoconstriction (recurrent nocturnal hypoxemia) Section 9: Renal and Urinary System Disorders (Questions 161-180) Nephrotic syndrome proteinuria – loss of negative charge on glomerular basement membrane (podocyte injury) ATN intrinsic renal phase – muddy brown granular casts, FENa 2% CKD metabolic acidosis – impaired distal hydrogen ion secretion (decreased net acid excretion) Acute interstitial nephritis (AIN) – pyuria with eosinophilia, white blood cell casts, sterile urine culture ADPKD hypertension – activation of RAAS (cyst-induced renal ischemia) Proteus UTI complication – struvite (magnesium ammonium phosphate) stone formation Nephrotic syndrome hyperlipidemia – increased hepatic synthesis of lipoproteins (low oncotic pressure) Diabetic nephropathy BP goal – SBP 130 mmHg, first-line ACE inhibitor or ARB 1cm radiopaque proximal ureter stone, urine pH 6.0 – calcium oxalate Hepatorenal syndrome (HRS) – severe renal vasoconstriction, low urinary sodium, preserved tubular function CKD stage 4 anemia – erythropoietin deficiency (reduced renal mass) AKI FENa 0.8%, urine osmolality 450 – prerenal azotemia Countercurrent multiplication – thick ascending limb of loop of Henle FSGS nephrotic syndrome – nephrotic-range proteinuria with dysmorphic red cells Hypercalciuria calcium oxalate stones – thiazide diuretics Diabetic nephropathy eGFR 35, UACR 500 – ACE inhibitor (slows progression) Membranous nephropathy biopsy – subepithelial immune deposits with spikes on silver stain ADPKD hypertension mechanism – increased renin secretion (cyst-related renal ischemia) Septic shock vasodilation – increased NO production by iNOS Hyperkalemia ECG life-threatening – widened QRS complex Section 10: Endocrine System Disorders (Questions 181-200) Type 2 diabetes elevated glucagon despite hyperglycemia – loss of paracrine inhibition by insulin (beta-cell dysfunction) Primary adrenal insufficiency – elevated plasma renin activity, low aldosterone Graves disease diagnostic finding – elevated TSH receptor antibodies (TRAb) DKA pathogenesis – enhanced lipolysis and oxidation of free fatty acids (insulin deficiency + elevated glucagon) Prolactinoma – autonomous prolactin secretion by adenoma Adrenal adenoma Cushing vs. Cushing disease – lack of cortisol suppression with high-dose dexamethasone Lithium nephrogenic diabetes insipidus – impaired aquaporin-2 translocation to collecting duct apical membrane Secondary hyperparathyroidism renal osteodystrophy – high bone turnover (osteitis fibrosa cystica) Post-thyroidectomy tetany – elevated serum phosphate, low serum calcium Euglycemic DKA with SGLT2 inhibitor – SGLT2 inhibitor therapy Type 1 diabetes morning hyperglycemia (no hypoglycemia) – dawn phenomenon (nocturnal growth hormone/cortisol surge) Thyroid storm laboratory findings – suppressed TSH, elevated free T4, elevated T3, elevated thyroid-stimulating immunoglobulins Adrenal adenoma preoperative critical derangement – hypokalemia and metabolic alkalosis Acromegaly OGTT pattern – baseline GH elevated, fails to suppress after glucose load, IGF-1 elevated Primary hyperaldosteronism – PRA low, aldosterone high, K low, metabolic alkalosis APS-1 additional deficiency – adrenal insufficiency (Addison's disease) SGLT2 inhibitor euglycemic DKA mechanism – increased glucagon secretion (reduced beta-cell glucose sensing) Post-pituitary surgery polyuria, desmopressin increases urine osmolality – central diabetes insipidus Hypopituitarism GI infection stress – double/triple glucocorticoid dose (stress-dose steroids) MEN1 hypercalcemia – parathyroid adenoma (primary hyperparathyroidism) Key features: 200+ questions covering all N212 Pathophysiology Exam 2 domains Detailed rationales with cellular mechanisms, molecular pathways, and clinical correlations Quantitative problems – ABG interpretation (Winter's formula), electrolyte calculations, FENa, urine osmolality Real-world scenarios – case-based questions integrating multiple pathophysiological concepts Updated for 2026 – reflects current Eastwick College N212 curriculum Perfect for – N212 Pathophysiology Exam 2, nursing pathophysiology, pre-nursing, pre-med, health sciences Last updated: [Insert current month/year] – reflects the latest N212 course objectives and pathophysiology standards

Content preview

N212 PATHOPHYSIOLOGY EXAM 2 (EASTWICK
COLLEGE) NEWEST 2026 ACTUAL EXAM| N212
PATHOPHYSIOLOGY EXAM 2 REVIEW WITH
COMPLETE REAL EXAM QUESTIONS AND CORRECT
VERIFIED ANSWERS/ ALREADY GRADED A+ (MOST
RECENT!!) — 200 Questions

Section 1: Cellular Injury and Adaptation (Questions 1-20)

1 In a patient with chronic gastroesophageal reflux disease, the squamous epithelium of the lower esophagus is
replaced by columnar epithelium. This adaptive response is best described as:
A) Metaplasia, which is a reversible change where one mature cell type is replaced by another, often due to
chronic irritation.
B) Dysplasia, characterized by disordered growth and cytologic atypia.
C) Hyperplasia, an increase in cell number without change in cell type.
D) Anaplasia, a loss of differentiation typical of malignant transformation.
Answer: A
Rationale: Barrett esophagus is a classic example of metaplasia, where chronic injury (acid reflux) induces
reprogramming of stem cells to a more resistant columnar phenotype. Dysplasia would show nuclear atypia;
hyperplasia involves increased cell number of the same type; anaplasia is a feature of cancer.

2 A laboratory experiment exposes cultured hepatocytes to a mitochondrial toxin that inhibits complex I of the
electron transport chain. Which of the following cellular consequences is most likely to occur FIRST?
A) Activation of caspase-9 via cytochrome c release.
B) Depletion of ATP and failure of the Na+/K+ ATPase pump.
C) Formation of reactive oxygen species (ROS) by the mitochondrial electron transport chain.
D) Swelling of the endoplasmic reticulum due to calcium influx.
Answer: B
Rationale: Inhibition of complex I rapidly reduces ATP production. ATP depletion impairs the Na+/K+ pump,
leading to cellular swelling. While ROS and calcium dysregulation occur, they are downstream events. Cytochrome
c release and caspase activation require mitochondrial outer membrane permeabilization, which is later.

3 Which of the following best explains why cardiac myocytes undergo hypertrophy rather than hyperplasia in
response to increased workload?
A) Cardiac myocytes are terminally differentiated and have exited the cell cycle, limiting their proliferative
capacity.
B) Hypertrophy provides a more efficient increase in contractile force compared to hyperplasia.
C) Hyperplasia would require angiogenesis, which is insufficient in the heart.
D) Cardiac myocytes lack growth factor receptors necessary for cell division.
Answer: A
Rationale: Cardiac myocytes are post-mitotic and cannot divide; thus, they respond to increased demand by
increasing cell size (hypertrophy). While efficiency and angiogenesis are considerations, the primary reason is the
lack of proliferative capacity. Growth factor receptors exist but do not trigger division.

,4 In a patient with a renal artery stenosis, the affected kidney shows a decrease in size and function. This adaptive
response is primarily mediated by:
A) Increased apoptosis due to chronic ischemia.
B) Atrophy resulting from reduced blood flow and decreased workload.
C) Necrosis of tubular epithelial cells from hypoxia.
D) Fibrosis replacing functional parenchyma.
Answer: B
Rationale: Reduced renal blood flow leads to decreased perfusion pressure and glomerular filtration, causing the
kidney to atrophy. Atrophy involves a decrease in cell size and number, often due to decreased workload, blood
supply, or trophic signals. Apoptosis contributes but is not the primary mechanism; necrosis would imply
irreversible injury.

5 A researcher treats cultured endothelial cells with a high dose of hydrogen peroxide. Within minutes, cells
exhibit swelling of mitochondria and loss of microvilli. However, upon removal of the oxidant, cells recover.
This stage of injury is best classified as:
A) Reversible cell injury, characterized by mitochondrial swelling and membrane blebbing that can be repaired.
B) Necrosis, because loss of microvilli indicates irreversible damage.
C) Apoptosis, as reactive oxygen species typically trigger programmed cell death.
D) Oncosis, a form of cell death with swelling and ATP depletion.
Answer: A
Rationale: The findings (mitochondrial swelling, loss of microvilli) are classic features of reversible injury. The key
is recovery after removal of the insult. Necrosis would involve irreversible changes like nuclear dissolution.
Apoptosis is characterized by cell shrinkage and nuclear fragmentation. Oncosis is a term for cell death with
swelling, but here recovery indicates reversibility.

6 In a histology section of a liver biopsy from a patient with viral hepatitis, some hepatocytes appear shrunken
with intensely eosinophilic cytoplasm and pyknotic nuclei. These cells are most likely undergoing:
A) Apoptosis, as evidenced by cell shrinkage and chromatin condensation.
B) Coagulative necrosis, with preservation of cell outlines.
C) Liquefactive necrosis, typical of viral infections.
D) Caseous necrosis, characterized by granular debris.
Answer: A
Rationale: Apoptotic cells (Councilman bodies in hepatitis) show shrinkage, eosinophilic cytoplasm, and pyknosis.
Coagulative necrosis retains cell outlines but with loss of nuclei. Liquefactive necrosis forms cysts; caseous
necrosis is crumbly and associated with granulomas.

7 Which of the following molecular events is most directly responsible for the transition from reversible to
irreversible cell injury during ischemia?
A) Depletion of ATP to less than 5% of normal levels.
B) Massive influx of calcium into the cytosol, activating phospholipases and proteases.
C) Formation of oxygen free radicals upon reperfusion.
D) Swelling of the endoplasmic reticulum due to failure of the SERCA pump.
Answer: B
Rationale: Irreversible injury is marked by severe mitochondrial dysfunction and loss of membrane integrity.
Calcium influx activates enzymes that degrade membranes and proteins, leading to cell death. ATP depletion is
critical but reversible if brief; reperfusion injury can exacerbate but is not the direct transition point.

,8 A patient with a genetic deficiency in superoxide dismutase (SOD) is expected to have increased susceptibility
to cell injury from:
A) Hypoxic injury, because SOD is required for mitochondrial respiration.
B) Reperfusion injury, as SOD normally scavenges superoxide radicals.
C) Chemical injury from heavy metals, which are detoxified by SOD.
D) Apoptosis triggered by DNA damage, as SOD repairs oxidative lesions.
Answer: B
Rationale: SOD converts superoxide (O2•") to hydrogen peroxide. Deficiency leads to accumulation of superoxide,
especially during reperfusion when oxygen is reintroduced, causing oxidative damage. SOD does not participate in
respiration, heavy metal detoxification, or direct DNA repair.

9 In a patient with chronic iron overload (hemochromatosis), hepatocytes show increased deposition of
hemosiderin. This is an example of:
A) Intracellular accumulation of an endogenous pigment due to excess substrate.
B) Dystrophic calcification resulting from cell injury.
C) Metaplastic change in response to iron toxicity.
D) Hyaline change, representing protein accumulation.
Answer: A
Rationale: Hemosiderin is a pigment derived from iron, accumulating when iron exceeds cellular storage capacity.
This is a form of intracellular accumulation, not calcification, metaplasia, or hyaline change. Dystrophic
calcification occurs in dead tissue; hyaline change is homogeneous eosinophilic material.

10 A researcher studies a novel drug that inhibits the unfolded protein response (UPR) in cells. Under conditions
of ER stress, cells treated with this drug would be more likely to:
A) Undergo autophagy to degrade misfolded proteins.
B) Activate the intrinsic apoptotic pathway via CHOP induction.
C) Fail to reduce misfolded protein load, leading to increased apoptosis.
D) Enhance proteasomal degradation of ER proteins.
Answer: C
Rationale: The UPR is a protective response that reduces misfolded proteins. Inhibiting it prevents adaptation, so
cells accumulate toxic proteins and undergo apoptosis. Autophagy is a separate process; CHOP is part of UPR but
its induction would be blocked; proteasomal degradation is not directly UPR-mediated.

11 In a cell exposed to chronic hypoxia, which molecular adaptation is most likely to be observed within the first
24 hours?
A) Upregulation of hypoxia-inducible factor 1± (HIF-1±) leading to increased erythropoietin transcription
B) Increased expression of pro-apoptotic BAX protein in the mitochondria
C) Activation of the unfolded protein response (UPR) due to ER stress
D) Stabilization of p53 and subsequent cell cycle arrest at G1/S checkpoint
Answer: A
Rationale: HIF-1± is rapidly stabilized under hypoxia and drives adaptive responses like erythropoietin production.
BAX upregulation promotes apoptosis, not adaptation. UPR is triggered by ER stress, not directly by hypoxia. p53
stabilization typically follows DNA damage, not isolated hypoxia.

12 A researcher treats cultured hepatocytes with a chemical that inhibits the proteasome. Which cellular adaptation
is most likely to be impaired?
A) Autophagy of damaged organelles

, B) Ubiquitin-mediated degradation of misfolded proteins
C) Heat shock protein (HSP) chaperone activity
D) Lysosomal acidification during heterophagy
Answer: B
Rationale: Proteasomes degrade ubiquitin-tagged proteins. Inhibition blocks this pathway. Autophagy involves
lysosomes, not proteasomes. HSP activity is independent of proteasomes. Lysosomal acidification is separate from
proteasomal degradation.

13 In a cell undergoing reversible cell injury, which ultrastructural change is typically the earliest detectable
event?
A) Nuclear pyknosis
B) Swelling of mitochondria and endoplasmic reticulum
C) Formation of amorphous densities in mitochondrial matrix
D) Fragmentation of the plasma membrane
Answer: B
Rationale: Cellular swelling due to failure of ion pumps is the earliest change. Pyknosis is a feature of irreversible
injury (necrosis). Amorphous densities indicate irreversible mitochondrial damage. Plasma membrane
fragmentation occurs late in necrosis.

14 A cell accumulates excessive iron due to a genetic defect. Which form of cell injury is most likely to result
from this accumulation?
A) Chemical injury via free radical generation
B) Hypoxic injury due to impaired oxygen diffusion
C) Immunologic injury from complement activation
D) Apoptotic injury via death receptor ligation
Answer: A
Rationale: Free iron catalyzes Fenton reactions producing hydroxyl radicals, causing oxidative stress. Iron overload
does not directly cause hypoxia or complement activation. Apoptosis from death receptors is triggered by specific
ligands, not iron.

15 Which of the following cellular adaptations is characterized by an increase in the number of cells in a tissue?
A) Atrophy
B) Hypertrophy
C) Hyperplasia
D) Metaplasia
Answer: C
Rationale: Hyperplasia is an increase in cell number. Atrophy is a decrease in cell size/number. Hypertrophy is
increase in cell size. Metaplasia is a change in cell type.

16 In a cell with defective autophagy, which cellular component is most likely to accumulate?
A) Polyubiquitinated proteins
B) Lipofuscin granules
C) Glycogen particles
D) Lipid droplets
Answer: B
Rationale: Autophagy removes damaged organelles and protein aggregates; lipofuscin is an indigestible pigment
that accumulates when autophagy is impaired. Polyubiquitinated proteins are cleared by proteasomes, not

Document information

Uploaded on
June 2, 2026
Number of pages
53
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$27.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
PremiumExamBank
4.8
(1057)
Sold
436
Followers
70
Items
6742
Last sold
1 day ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions